The selective inhibition of the α-CAs IX and XII isoforms has emerged as a promising target in anticancer research [16], due to their role in acidifying the hypoxic tumor microenvironment, which promotes tumor progression and metastasis [17]. The gene discussed is CA9; the disease is neoplasm.